Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Diabetic Polyneuropathy
NCT01622777Phase 2Completed
- Start
- Feb 2010
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing Rosuvastatin with Placebo (2 arms). Primary endpoints: Stage of diabetic polyneuropathy at 12 weeks, Severity of diabetic polyneuropathy at 12 weeks and 4 more. Started Feb 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT01622777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01622777.